Cytokine-Driven NF-κB Activation in Retinal Cells and Its Impact on the Pathogenesis of Age-Related Macular Degeneration: A Systematic Review
Viqas Shafi,Nabeel Ahmad Khan,Javeria Kazmi,Ifrah Siddiqui
DOI: https://doi.org/10.1101/2024.10.06.24314951
2024-10-07
Abstract:Objective:
To investigate the role of cytokine-induced NF-κB activation in retinal pigment epithelium (RPE) and photoreceptor cells, elucidating its contribution to the pathogenesis of Age-related Macular Degeneration (AMD) and identifying potential therapeutic targets.
Background:
AMD is a leading cause of vision loss in older adults, driven by inflammation, oxidative stress, and immune dysregulation, particularly in RPE and photoreceptor cells. The NF-κB signaling pathway, activated by cytokines such as TNF-α, IL-6, and IL-1β, regulates these pathological processes. Understanding cytokine-induced NF-κB activation may provide insight into AMD progression and facilitate the development of novel therapeutic strategies.
Methods:
A systematic review of literature from databases including PubMed, MEDLINE, and Google Scholar was conducted to evaluate the involvement of TNF-α, IL-6, IL-1β, IL-8, IFN-γ, IL-17, IL-12, IL-18, IL-33, and IL-25 in activating NF-κB in RPE and photoreceptor cells, contributing to AMD pathogenesis. The search was performed with no date restrictions and followed PRISMA guidelines. Eligible studies were selected based on predefined criteria assessing NF-κB activation mechanisms and its effects on inflammation, oxidative stress, and retinal degeneration.
Results:
The investigation revealed that cytokines TNF-α, IL-6, IL-1β, IL-8, IFN-γ, IL-17, IL-12, IL-18, IL-33, and IL-25 activate the NF-κB signaling pathway in retinal pigment epithelium (RPE) and photoreceptor cells. This activation triggers the transcription of genes involved in inflammation, oxidative stress, and immune responses. Chronic NF-κB activation leads to persistent inflammation, increased oxidative stress, and immune cell recruitment, contributing to retinal cell dysfunction and degeneration. Additionally, NF-κB-driven upregulation of angiogenic factors such as VEGF promotes neovascularization in wet AMD. These findings highlight the central role of NF-κB in AMD pathogenesis and suggest that targeting this pathway could mitigate inflammatory and oxidative damage, offering potential therapeutic benefits for AMD patients.
Conclusion:
Cytokine-induced NF-κB activation plays a central role in AMD pathogenesis by promoting chronic inflammation, oxidative stress, and angiogenesis in retinal cells. Targeting NF-κB could present a therapeutic strategy to reduce inflammatory and oxidative damage, preserving retinal function and preventing vision loss in AMD. Further research is required to develop effective NF-κB-targeted interventions.
Allergy and Immunology